High rates of multi-drug resistant gram-negative organisms associated with surgical site infections in a teaching hospital in Ghana

Abstract

Background

There is limited data to guide the prevention and management of surgical site infections (SSI) in low- and middle-income countries. We prospectively studied aetiological agents associated with SSI and their corresponding antibiotic susceptibility patterns in a tertiary hospital in Ghana.

Methods

As part of a cohort study carried out at the surgical department of the Korle Bu Teaching Hospital (KBTH) from July 2017 to April 2019, wound swabs were collected from patients diagnosed with SSI. Isolates cultured from the wound swabs were identified by MALDI TOF and susceptibility testing was conducted according to EUCAST 2020 guidelines. Clinical data were monitored prospectively.

Results

Of 4577 patients, 438 developed an SSI and 352 microbial isolates were cultured. Isolates were predominantly Gram negative (286, 81%), a pattern seen for all kinds of surgery and all wound classes. The most common species included Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Acinetobacter baumannii. The majority of organisms were multi-drug resistant including 86% of E. coli, 52% of A. baumannii and 86% of K. pneumoniae; and 65% (17/26) of the cefotaxime-resistant K. pneumoniae were extended spectrum β-lactamase producing. One of 139 E. coli, 15 of 49 P. aeruginosa, and 6 of 23 A. baumannii were meropenem resistant, but no clonal pattern was found. There was a 1% (5/428) prevalence of methicillin-resistant S. aureus.

Conclusions

The predominance of Gram-negative organisms and the high level of multi-drug resistance indicate a need to re-evaluate antibiotic prophylaxis and treatment protocols in surgical practice in low- and middle-income countries.

Background

Surgical site infections (SSI) is a major type of healthcare associated infections (HCAI), forming as much as 33% of all HCAI in sub-Saharan Africa [1, 2]. A major teaching hospital in Ghana also described an SSI incidence risk of 10% with an associated 9 extra days of stay and $1519 excess cost to the institution per patient [3, 4].

The global spread of antibiotic resistance further compounds the problem of SSI. Infections caused by resistant bacteria lead to poor treatment outcomes. Major drivers of antimicrobial resistance in low- and middle-income countries include inappropriate prescription practices and poor infection control measures [5]. Thus, the prevalence of antibiotic use among surgical patients in sub-Saharan Africa is 24–73% [6], and the majority of these antibiotics are prescribed for prophylaxis and usually beyond the recommended 24-h period [7]. Reasons for this prolonged antibiotic use include a fear of infections due to poor infection control [8].

In Ghana, as in most low- and middle-income countries, antimicrobial treatment of wound infections is mainly empirical due to limited laboratory services in most health facilities and the costs to patients of culture and susceptibility testing, when available [9]. The selection of prophylactic antibiotic therapy is based on the operation site and the normal resident flora. Thus, empirical choice of antibiotics relies on knowledge of the susceptibility patterns of common local pathogens. Absence of this data precludes rational use of antibiotics for treatment and prevention of SSI.

In this study, we prospectively identified the aetiological agents of SSI at the surgical department of a tertiary hospital in Ghana, with emphasis on their antibiotic susceptibility patterns, and related to the patient characteristics.

Methods

Study site, patient recruitment and collection of samples

Samples were collected as part of a cohort study at the surgical department of the Korle Bu Teaching Hospital from July 2017 to April 2019. The study design and results (for the period July 2017–December 2018) of the surveillance have been reported elsewhere [3]. All patients who underwent surgery in the unit were followed actively for the occurrence of SSI during admission and post-discharge for 30 days, and infection was defined according to Centers of Disease Control and Prevention (CDC) criteria [3, 10]. Wound contamination and SSI type were classified based on the CDC classification [10]. Implant surgery and surgery with wounds that could not be closed immediately were excluded.

Patients on admission had their change of dressing carried out on their bed in the wards. Post-discharge change of dressing was carried out in dressing rooms situated on each ward. Wound swabs were taken from consecutive patients diagnosed with SSI, either on admission or post discharge for microbiology analysis. The project staff had been trained to carefully collect exudate from the infected surgical site using sterile cotton- tipped applicators (Sterilin, U.K), which were transferred to the microbiology laboratory within an hour of sampling. Preliminary culture and susceptibility results were reported immediately to the physicians for management of patients. Isolates were then frozen at − 80 °C and transported to Copenhagen for confirmatory testing and additional analyses.

Laboratory analyses

Wound swabs were cultured on blood, chocolate and MacConkey agar plates. Isolates were identified using MALDI TOF Biotyper (Bruker Daltonics, Bremen, Germany). Here, susceptibility testing was conducted according to EUCAST 2020 guidelines [11]. The following discs were used; ampicillin (10 μg), amoxicillin-clavulanate (20/10 μg), gentamicin (10 μg), amikacin (30 μg), ciprofloxacin (5 μg), cefuroxime (30 μg), ceftazidime (10 μg), ceftriaxone (30 μg), cefotaxime (10 μg), tazobactam-piperracillin (30/6 μg), meropenem (10 μg), cefoxitin (30 μg), erythromycin (15 μg), clindamycin (2 μg), sulphamethoxazole-trimethoprim (25 μg), penicillin (1 unit), linezolid (10 μg), tetracycline (30 μg), (all from Oxoid Ltd., Basingstoke, United Kingdom (UK)). Isolates were categorized as “resistant” and “susceptible”, including those “susceptible at increased exposure” also classified as “susceptible” [12]. E. coli ATCC 25922 and Staphylococcus aureus ATCC 25923 were used as controls for Gram negative and positive panels respectively. Klebsiella pneumoniae ATCC 700603 was used as quality control strains for ESBL screening.

Enterobacterales resistant to third generation cephalosporins were screened for production of extended spectrum beta lactamases (ESBL) using the double disc diffusion method [13]. Isolates with phenotypic resistance to meropenem were screened depending on the species. Pseudomonas spp. were screened for carbapenemases using GeneXpert (Xpert® Carba-R, Cepheid, France), Acinetobacter spp. were screened for OXA-23 using a rapid diagnostic test (OXA-23 K-SeT, Coris, Belgium), and Acinetobacter spp. and enterobacterales were screened for carbapenemases using NG-CARBA 5® (Hardy Diagnostics, CA, USA). All Staphylococcus aureus isolates were screened for methicillin resistance using cefoxitin. Multidrug resistance (MDR) was defined as resistance to ≥1 antibiotic in ≥3 antibiotic groups [14].

Data analysis

For each bacterial agent, the percentage frequency of resistant isolates was determined. The resistance patterns of isolates of the same species were screened visually for possible clonal distribution. Distribution of bacterial types by clinical groups were compared by chi-square test and p < 0.05 was considered significant. We used Stata /MP version 15.1 (Stata Corp., College Station, Tx, USA) for the analysis.

Results

Demographic and patient characteristics

A total of 4577 patients were included in the study. Of these, 438 (9.6%) patients, developed an SSI. The SSI risk was 9.3% (376/4054) in the general surgical department, 26.5% (31/117) in the department of urology and 7.6% (31/406) in paediatric surgery. The median age of the patients who developed an SSI was 45 years (interquartile range 31–60 years) and 239 (54%) patients were female.

From 382 (87%) of the 438 patients, a wound swab was taken for microbiological analysis. No wound swabs were taken in 13% (56/438) of the cases due to; surveillance team missing the opportunity to take a swab at change of wound dressing or at a relaparotomy for an SSI, missing the diagnosis of an SSI until the attention was drawn to the clinical signs and, wound swabs taken but accidentally sent to a private laboratory for analysis.

Characteristics of surgical wounds

The proportion of patients who developed an SSI was 5.2% (135/2589) for wounds classified as clean, 10.1% (66/655) for a clean contaminated wound, 12.1% (104/859) for contaminated and 27.4% (130/475) for dirty wounds.

We found 352 isolates in 327 (86%) of the 382 swabs. Most were monoculture, but two different species were cultured from each of 25 swabs. Isolates from clean wounds accounted for 29% (103/352) of isolates, clean contaminated wounds for 14% (48), contaminated wounds for 26% (91), and dirty wounds for 31% (110) of isolated microorganisms.

Aetiology of surgical site infections

Gram-negative microorganisms constituted 81% (286/352) of the isolates. The five most common microorganisms were Escherichia coli (139, 39%), Pseudomonas aeruginosa (49, 14%), Klebsiella pneumoniae (35, 10%), Staphylococcus aureus (33, 9%) and Acinetobacter baumannii (23, 6%), accounting for approximately 79% of the isolated organisms (Table 1).

Table 1.

Microbial isolates from infected surgical sites in a teaching hospital in Ghana

Clinical isolates	N	%	Number of isolates with multidrug resistance (%)	Extended spectrum β-lactamase-producing isolates (%)	Meropenem resistant isolatesa (%)	Number of isolates with methicillin resistance (%)
Escherichia coli	139	39.5	120 (86%)	50 (36%)	1 (1%)	–
Pseudomonas spp.	49	13.9	17 (35%)	–	15 (31%)	–
Klebsiella pneumonia	35	9.9	30 (86%)	17 (48%)	0	–
Staphylococcus aureus	33	9.4	8 (24%)	–	–	5 (15%)
Acinetobacter baumannii	23	6.5	12 (52%)	–	6 (26%)	–
Proteus spp.	21	6.0	5 (24%)	0	0	–
Staphylococcus haemolyticus	15	4.3	14 (93%)	–	–	0
Staphylococcus epidermidis	11	3.1	10 (91%)	–	–	0
Enterobacter spp.	11	3.1	5 (45%)	2 (18%)	0	–
Corynebacterium spp.	4	1.1	1 (25%)	–	–	–
Candida albicans	2	0.6	ND	–	–	–
Achromobacter spp.	2	0.6	1 (50%)	–	0	–
Stenotrophomonas maltophilia	2	0.6	0	–	0	–
Providencia stuartii	2	0.6	0	–	0	–
Staphylococcus lugdunensis	1	0.3	0	–	–	0
Alcaligenes faecalis	1	0.3	1 (100%)	–	–	–
Morganella morganii	1	0.3	1 (100%)	–	0	–

^a Four P. aeruginosa had the vim (Verona integron-encoded metallo-β-lactamase) gene and one A. baumannii produced OXA-23

Table 2 describes the pathogens by type of surgery. At least one isolate was found in 187 patients (11%) of the 1646 gastrointestinal and other abdominal surgeries, in 12 (8%) of 140 genitourinary and prostate surgeries, 38 (4%) of 907 breast surgeries, 44 (5%) of 866 hernia and scrotal surgeries, 25 (16%) of 157 limb amputations, 9 (3%) of 307 thyroid surgeries and 12 (2%) of 554 other soft tissue surgeries. The ratio between Gram-negative and Gram-positive organisms differed by type of surgery (Table 3, p = 0.002). For gastro-intestinal and genito-urinary surgery, Staphylococcus spp. constituted < 16% of the isolates, whereas Staphylococcus spp. constituted > 25% of the isolates for hernia, breast, soft tissue and thyroid surgery. Despite this difference, Gram-negative organisms constituted ≥66% of isolates for all types of surgery and as much as 87% for gastro-intestinal surgery.

Table 2.

Distribution of microbial isolates in relation to type of surgical procedure

Procedure performed	Total n = 4577	SSI n = 438	E. coli n = 139	Pseudomonas spp. n = 49	Klebsiella spp. n = 35	A. baumannii n = 23	Proteus spp. n = 21	Enterobacter spp. n = 11	S. aureus n = 33	CoNS n = 27	Others n = 14	No growth n = 55	No samples n = 56
Gastrointestinal + other abdominal surgery	1646	253	117	15	21	18	4	4	6	16	5	33	33
Hernia + scrotal surgery	866	54	12	4	3	1	6	2	10	6	3	5	5
Breast surgery	907	49	3	13	3	2	6	0	8	3	2	5	6
Limb amputation	157	33	5	7	5	0	0	2	3	1	3	3	5
Genitourinary tract + prostate surgery	140	20	2	5	1	0	1	1	1	0	1	4	4
Other soft tissue surgery	554	16	0	2	2	1	2	1	3	0	0	2	2
Thyroid surgery	307	13	0	3	0	1	2	1	2	1	0	3	1

SSI surgical site infections

CoNS include S. haemolyticus and S. epidermidis and S. lugdunensis. Other microbial isolates include Corynebacterium spp., C. albicans, Achromobacter spp., S. maltophilia, P. stuartii, A. faecalis and M. morganii

Table 3.

Comparison of distribution of Gram negative: Gram positive for type of procedure performed and type of SSI

Clinical characteristics	Total number of positive cultures n = 352	Total number of Gram-negative organisms n = 286	Gram-negative organisms %	Total number of Staphylococcus spp.(60) + other Gram-positive organisms (4) n = 64	Staphylococcus spp. + Other Gram-positive organisms %	Total number of other microbial isolates (fungi) n = 2	Other microbial isolates (fungi) %
Procedure performed
Gastrointestinal + other abdominal surgery	207	181	87.4	24	11.6	2	1.0
Hernia + scrotal surgery	47	31	65.9	16	34.0	0	0.0
Breast surgery	40	29	72.5	11	27.5	0	0.0
Limb amputation	26	21	80.8	5	19.2	0	0.0
Genitourinary tract + prostate surgery	12	10	83.3	2	16.7	0	0.0
Other soft tissue surgery	10	7	70.0	3	30.0	0	0.0
Thyroid surgery	10	7	70.0	3	30.0	0	0.0
Type of SSI
Superficial	291	228	78.3	61	21.0	2	0.7
Deep	34	31	85.3	3	8.8	0	0.0
Organ space	27	27	100.0	0	0.0	0	0.0

There was a difference between type of wound and the ratio between Gram-negative and Gram-positive organisms (Table 3), and S. aureus was only cultured from superficial SSI (Table 4). Conversely, all isolates from organ-space SSI were Gram negative. A much higher proportion of organ/space infections than other types of infections were not cultured, mostly due to the surveillance team missing the opportunity to take a wound swab during a relaparotomy to drain abscesses.

Table 4.

Distribution of microbial isolates in relation to type of surgical site infection (SSI)

Type of SSI	Number with surgical site infections	E. coli n = 139	Pseudomonas spp. n = 49	Klebsiella spp. n = 35	A. baumannii n = 23	Proteus spp. n = 21	Enterobacter spp. n = 11	S. aureus n = 33	CoNS n = 27	Others n = 14	No growth n = 55	No samples n = 56
Superficial SSI	366 (%)	105 (29%)	42 (11%)	29 (8%)	18 (5%)	18 (5%)	10 (3%)	33 (9%)	24 (6%)	12 (3%)	45 (12%)	30 (8%)
Deep SSI	49 (%)	17 (34%)	3 (6%)	2 (4%)	4 (8%)	2 (4%)	1 (2%)	0	3 (6%)	2 (4%)	7 (14%)	8 (16%)
Organ-space SSI	48 (%)	17 (35%)	4 (8%)	4 (8%)	1 (2%)	1 (2%)	0	0	0	0	3 (6%)	18 (37%)

CoNS include S. haemolyticus and S. epidermidis and S. lugdunensis. Other microbial isolates include Corynebacterium spp., C. albicans, Achromobacter spp., S. maltophilia, P. stuartii, A. faecalis and M. morganii

Antimicrobial susceptibility patterns

The majority of bacterial isolates were MDR, ranging from 23 to 86% for Proteus spp. and E. coli isolates, respectively (Table 1). Acquired resistance to commonly used antibiotics ranged from 1% to meropenem in E. coli to 95% to ampicillin, ciprofloxacin and trimethoprim-sulphamethoxazole in E. coli (Fig. 1a).

Fig. 1.

Antibiotic resistance pattern for bacteria isolated from infected surgical sites. a, Eschericia coli, Klebsiella spp. and Proteus spp., b, Pseudomonas aeruginosa and Acinetobacter baumannii, c. Staphylococcus spp. AMC – amoxicillin/clavulanic acid, AMK – amikacin, AMP – ampicillin, CAZ – ceftazidime, CIP – ciprofloxacin, CLI – clindamycin, CRO – ceftriazone, CTL – cefotaxime + clavulanic acid, CXM – cefuroxime, E – erythromycin, FOX – cefoxitin, GEN – gentamycin, LZD – linezolid, MEM – meropenem, SXT – trimethoprim-sulphamethoxazole, TE – tetracycline, TZP – piperacillin/tazobactam

Among E. coli and K. pneumoniae isolates, 60% (82/139) and 74% (26/35), respectively were resistant to third generation cephalosporins. Sixty-one percent (50/82) and 65% (17/26) of the cefotaxime-resistant E. coli and K. pneumoniae, respectively were ESBL producing.

Meropenem resistance in this study was mainly found in Pseudomonas spp. (15 of 49 isolates) and Acinetobacter baumannii (6 of 23 isolates) (Table 1, Fig. 1b). Four P. aeruginosa isolates harboured the vim gene, encoding Verona integron-encoded metallo-β-lactamase. One A. baumannii expressed OXA-23. K. pneumoniae showed no resistance to meropenem (Fig. 1a).

Fifteen percent (5/33) of S. aureus isolates were methicillin resistant (MRSA). Overall, the MRSA prevalence was 1% (5/438) in the cultured wounds. Resistance of S. aureus against other antibiotics ranged from 6% to gentamycin and clindamycin to 42% to tetracycline. Among coagulase-negative staphylococci, the percentage resistance ranged from 23% to clindamycin to 81% to tetracycline. Neither S. aureus nor coagulase negative staphylococci showed resistance to linezolid (Fig. 1c).

The sensitivity pattern of the MDR organisms, including those for which specific resistance mechanisms such as ESBL or carbapenemases were detected, did not give any indication of an outbreak of one or more clones (data not shown).

Discussion

In this study, from a surgical facility in Africa, Gram-negative rods were the primary aetiology of SSI. Despite differences in ratios between Gram-negative and Gram-positive organisms by types of surgery and SSI types, Gram-negatives dominated in all categories. There was a high level of MDR among isolated organisms, including carbapenem-resistant P. aeruginosa and A. baumannii and ESBL-producing E. coli and K. pneumoniae. There was no phenotypic indication of clonality of the MDR organisms, indicating that the findings could not be explained by an outbreak. These findings challenge the standard recommendations for empiric prevention and treatment of SSI in low- and middle-income countries.

Unlike earlier studies in Ghana, which recorded low rates of microbiology testing [9], this study recorded a high rate of testing. This can be explained by the fact that under the active study conditions, wound swab samples were taken by the surveillance team when an SSI was diagnosed, irrespective of the clinicians’ diagnosis, and the cost of the testing was also borne by the study. In low- and middle-income countries, low rates of microbiology testing are often reported, presumably due to the limited facilities for microbiology testing, the costs of testing, limited numbers of trained personnel, and the tendency for clinicians to underutilize existing microbiology facilities [9, 15–18] As reported previously, the active surveillance and access to microbiological testing in this study lead to immediate improvements in SSI rates in the course of the study [3].

E. coli was the commonest isolated organism, whereas, S. aureus and coagulase negative staphylococci constituted less than a fifth of the isolates. Some studies have also predominantly isolated E. coli from infected surgical sites post abdominal surgeries [19, 20] but in most studies in Africa, S. aureus was the most common pathogen isolated from SSI [21]. The large numbers of gastrointestinal surgeries performed in this study cannot fully explain the predominance of E. coli since Gram-negative rods were the predominant aetiology of SSI in all forms of surgery. A possible explanation of this could be a high rate of skin carriage of Gram-negative organisms as shown in a study from Tanzania [22]. In addition, the routine use of antibiotic prophylaxis with an effect on S. aureus in our department coupled with a relatively low rate of methicillin resistance may also have skewed the distribution of microorganisms toward Gram negatives. Finally we recently found high levels of antimicrobial air contamination in our surgical facility and demonstrated a causal relationship with SSI [23]. This study indicated that air contamination may have contributed to infections with environmental bacteria such as P. aeruginosa and A. baumannii, whereas enterobacterales were uncommon in the air samples.

Skin carriage of Gram-negative organisms may be associated with previous antibiotic use. In line with this, it is likely our patients had received antibiotic therapy at referring facilities before coming to our tertiary hospital, where the treatment may have been continued. We have recently documented long periods of administration of antibiotics in surgical units in Ghana, at all levels of health facilities [9]. Long periods of administration of antibiotics have also been reported in other health facilities in low- and middle-income countries [24, 25].

The high usage of antibiotics coupled with the low rate of microbiology testing to inform choice of antibiotic therapy, may explain the high levels of MDR. Hospital-based antimicrobial stewardship programs are said to decrease antibiotic use, though data on this is limited in low- and middle-income countries [26]. There is a need to develop and document the effect of functioning antibiotic stewardship programs based on longitudinal monitoring of microbiological test results from the surgical department.

The choice of antibiotics in the department is essentially based on the Ghana standard treatment guidelines, usually reviewed at intervals of 5 years or more [27, 28].

Antibiotics like ciprofloxacin are used routinely by surgeons as therapeutic and prophylactic treatment for gastrointestinal surgery, and in combination with clindamycin for limb amputation for dry and wet lower limb gangrene. The high prevalence of ciprofloxacin resistance in this study, ranging between 95 and 33% among E. coli and S. aureus respectively, shows the evolving pattern of resistance. In comparison, a 10% resistance to ciprofloxacin in fecal E. coli has been reported in the past [29]. Conversely, the low resistance to vancomycin, piperacillin/tazobactam and linezolid may reflect their low usage or unavailability in most Ghanaian facilities, based on the essential medicines list of the ministry of health [27].

The low prevalence of MRSA confirms previous findings from inpatients in our institution [30]. A high use of amoxicillin/clavulanic acid may explain the low frequency of S. aureus in our study, but the high prevalence of amoxicillin/clavulanic acid-resistant Gram-negative organisms suggests the need to re-evaluate the protocols.

The resistance to 3rd generation cephalosporins by K. pneumoniae and E. coli in our study was mainly caused by ESBL. This cannot be explained by a high usage of third generation cephalosporins as the Ghana treatment guidelines do not recommend this drug class. We have recently reported clonal outbreaks of MDR K. pneumoniae in neonatal intensive care units in Ghana [31], but in the present study we did not find indication of ongoing outbreaks, based on phenotypic analysis. The high ESBL rate may thus mimic antibiotic resistance in patients’ own flora indicating widespread carriage of resistant organisms in the society [32].

This study involves data from only one hospital, limiting the generalization of the results, though the hospital serves as a major referral center for a population of over 30 million.

Conclusion

Gram-negative organisms with a high level of MDR were the predominant organisms isolated from SSI. Antibiotic treatment protocols including prophylactic strategies need to be re-evaluated to improve outcomes and minimize the emergence of antimicrobial resistance.

Abbreviations

CDC

Centers for Disease Control and Prevention

Corp.

Corporation

ESBL

Extended spectrum beta lactamases

HCAI

Healthcare associated infections

KBTH

Korle Bu Teaching Hospital

MDR

Multidrug resistant

MRSA

Methicillin resistant Staphylococcus aureus

SSI

Surgical site infections

Tx.

Texas

UK

United Kingdom

USA

United State of America

Authors’ contributions

ABB, JALK, KM, AKL, EO, and MJN conceptualized the study; participated in its design, coordination and helped to draft the manuscript. ABB collected data and performed the statistical analysis with help of KM. JALK and AKL contributed to microbiological testing. The manuscript was revised for intellectual content by KM, JALK and MJN. All authors have read and approved the final manuscript for submission.

Funding

This work was supported by DANIDA through the HAI-GHANA PROJECT, [grant number 16-PO1-GHA]. The funder had no role in study design, data collection, analysis and preparation of this manuscript.

Availability of data and materials

Data is available from corresponding author upon request.

Ethics approval and consent to participate

Ethical approval was granted by the Korle Bu Teaching Hospital Institutional Review Board, KBTH-STC/IRB/00022/2017 and the College of Health Sciences’ Ethical and Protocol review committee, CHS-Et/M.8-P4.5/2016–2017. All patients gave a written, informed consent.

Consent for publication

Not applicable.

Competing interests

None declared.